Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026fool.com
The Chief Scientific Officer of Scholar Rock Holding Corp has made multiple filings regarding disposals in January 2026, but this should not alarm investors.
Via The Motley Fool · February 1, 2026
3 Questions Investors Should Answer Before Buying Beyond Meat Stock​fool.com
Beyond Meat was a market darling when it first went public, but you'll want to tread cautiously if you are looking to buy it today.
Via The Motley Fool · February 1, 2026
Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120Mfool.com
A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025.
Via The Motley Fool · February 1, 2026
Should You Buy Nio Stock While It's Below $5 a Share?​fool.com
Nio is an innovative auto company operating in the world's largest auto market, but I'm still bearish on it.
Via The Motley Fool · February 1, 2026
Market At Risk Of Correcting In A 'Risk-Off' Reset?talkmarkets.com
Stocks have been stuck in a compressing trading range for the past several months.
Via Talk Markets · January 31, 2026
This Nearly 4%-Yielding Energy Stock Delivered Powerful Growth in 2025 With More to Come in 2026 and Beyondfool.com
Brookfield Renewable has high-powered total return potential.
Via The Motley Fool · February 1, 2026
Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500kfool.com
The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.
Via The Motley Fool · February 1, 2026
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxesfool.com
The chief medical officer at one of the top pharmaceutical companies sold nearly 10,000 shares in late January 2026, but the reason was for something very simple.
Via The Motley Fool · February 1, 2026
1 Underrated Reason Netflix's Growth Story Isn't Overfool.com
The streaming giant's stock is trading at much lower levels than it was a year ago.
Via The Motley Fool · February 1, 2026
Pete Buttigieg Says Trump 'Failed To Bring Down Prices,' Warns Affordability Crisis Is Hitting American Familiesbenzinga.com
Transportation Secretary Pete Buttigieg criticized Trump administration and Republicans for rising costs, stalled healthcare relief.
Via Benzinga · February 1, 2026
3 AI Stocks to Buy in 2026 and Hold Foreverfool.com
AI will have a lasting effect on the market.
Via The Motley Fool · February 1, 2026
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Millionfool.com
A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock performance. But the sale is not what it seems.
Via The Motley Fool · February 1, 2026
Costco Stock Is Soaring. Is It Too Late to Buy?fool.com
The market is embracing the retail king again.
Via The Motley Fool · February 1, 2026
The AI Bubble Narrative Just Got Flipped On Its Head. Here's What Investors Need To Know.fool.com
According to the latest movement, AI could be more disruptive than we thought.
Via The Motley Fool · January 31, 2026
Trump's AI, Crypto Czar David Sacks Says Democrats Oppose Deportations To Preserve Political Power Basebenzinga.com
David Sacks said Democratic opposition to mass deportations is driven by political calculations, citing census data.
Via Benzinga · February 1, 2026
Bernie Sanders, Elizabeth Warren, Other Democrats Push To Slash $75 Billion ICE Funding, Restore Health Care Cuts In Trump's Spending Lawbenzinga.com
Democrats press Congress to cut $75 billion in funding for ICE and use it to restore healthcare programs affected by Trump's spending law.
Via Benzinga · February 1, 2026
4 Ways to Set Your 401(k) Up for Success in 2026fool.com
With the right strategy, you can grow your savings nicely this year.
Via The Motley Fool · January 31, 2026
Investment Firm Bouvel Raised Its Stake in This ETF by $8 Million. Is It a Buy?fool.com
This actively managed fixed income ETF targets diversified bond exposure and reported a 5.09% annualized yield in its latest filing.
Via The Motley Fool · January 31, 2026
Forget BigBear.ai: This Mission‑Critical AI Platform With Exploding Commercial Revenue Is the Better Long‑Term Betfool.com
An overreliance on government contracts is turning out to be a headwind for BigBear.ai.
Via The Motley Fool · January 31, 2026
Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800fool.com
This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership in mid-January 2026.
Via The Motley Fool · January 31, 2026
Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800fool.com
This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.
Via The Motley Fool · January 31, 2026
2 Financial Stocks Poised for a Comeback in 2026fool.com
The sell-off in Mastercard and Visa is a tremendous buying opportunity for long-term investors.
Via The Motley Fool · January 31, 2026
2 High-Flying Electric Vehicle Stocks Have Serious Momentum -- But Are They Buys?fool.com
These two EV stocks are hot topics in the automotive industry, but only one is a buy for risk-tolerant investors.
Via The Motley Fool · January 31, 2026
Arcellx Director Sells 6,000 Shares for $450,000fool.com
A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid the company's stock having an underwhelming performance in 2025.
Via The Motley Fool · January 31, 2026
Is This Fixed Income ETF a Buy After Symmetry Partners Initiated a Large Position Valued at Nearly $134 Million?fool.com
The Dimensional Global Core Plus Fixed Income ETF offers access to global bonds spanning government, corporate, and securitized markets.
Via The Motley Fool · January 31, 2026